Clinical study of Jinshuibao Capsule to improve ivF-ET pregnancy outcome in infertile patients with renal deficiency and ovarian reserve dysfunction

China Welfare Association International Peace Maternal and Child Health Hospital0 个研究点开始时间: 待定最近更新: 2023年2月20日

适应症

试验速览

暂无简介。

•(1) The age range is 18 to 39;
•(2) It conforms to the diagnostic criteria of western medicine and Chinese medicine at the same time;
•(3) All planned to perform IVF-ET transplantation in the Reproductive Center of The International Peace Maternal and Child Health Center of China Welfare Association (ADOPT GNRH-A ultra-long natural cycle freeze-thawed embryo transplantation D3);
•(4) those who have not taken medication or have taken medication but have stopped taking medication for more than 3 months;
•(5) Volunteer to participate in this clinical study and sign the relevant informed consent.

•(1) Any contraindications in accordance with IVF-ET and its derived technologies shall be excluded;
•(2) Those who have used hormone drugs in recent 3 months;
•(3) Infertility caused by ovulation disorders, immune factors and chromosomal abnormalities;
•(4) Abnormal analysis of male semen;
•(5) Persons with a history of severe drug allergy;
•(6) Patients with breast or other reproductive organ diseases, such as multiple uterine fibroids, polycystic ovary syndrome, endometriosis, malformation of reproductive organs or physiological defects, or those with serious medical diseases;
•(7) People who are allergic to multiple drugs or have known allergies to the components of this drug;
•(8) Participating in other clinical trial projects.

发起方

China Welfare Association International Peace Maternal and Child Health Hospital